Until now, RhD-negative pregnant women were generally advised to take rhesus prophylaxis. Now, thanks to our new FastQ^® RHD fetal, targeted anti-D prophylaxis is possible by using modern non-invasive molecular fetal diagnostics via real-time PCR typing.

Reliably typing even more variants of the corona virus SARS-CoV-2! With the new differentiation kit ViroQ^® SC2 Variant 2, even more deviations from the virus of origin can be reliably detected.

Innovation in virological infectiology: The new real-time rapid test ViroQ SARS-FluA/B-RSV. The new test reliably detectss with just one PCR run SARS-CoV-2, RS, Influenza A and B viruses.

With our new distribution partner Sysmex America, Inc. the PCR rapid test for the safe detection of SARS CoV-2 is now also available in the USA and Canada. FDA EUA certification has already been submitted.

BAG Diagnostics has developed a rapid test that transcribes and amplifies the RNA from SARS-CoV-2 to cDNA in a one-step PCR procedure. The kit is the first test to check whether there is enough cell material in the sample smear to produce a valid negative result.